Home » News

Jeremiah Brown Appointed Chair of NIH Study Section

Jeremiah Brown, PhD, a professor of epidemiology, of The Dartmouth Institute for Health Policy and Clinical Practice and of biomedical data science at Dartmouth’s Geisel School of Medicine, has been named Chair of the Science of Implementation in Health and Healthcare Study Section (SIHH), a standing study section in the Center for Scientific Review at the National Institutes of Health (NIH). He begins his two-year term effective July 1, 2022.

Through his work in healthcare improvement and cardiovascular epidemiology, Brown has emerged as a leading presence in the field of implementation science. This new area of multidisciplinary research, which focuses on moving scientific evidence into routine practice, has quickly become a top priority for major funding organizations such as the NIH, CDC, and PCORI (Patient-Centered Outcomes Research Institute).

Jeremiah Brown, PhD. Photo by Kurt Wehde

“I am very pleased that Dr. Brown has been selected for this key national leadership position,” says Duane Compton, PhD, dean of the Geisel School of Medicine. “This appointment recognizes his many accomplishments in academic medicine and will provide him with a unique opportunity to contribute to the national biomedical research effort.”

In his role as chair, Brown’s responsibilities will include running the scientific review meeting, managing the grant review process to ensure that it is fair, equitable and free of bias, addressing areas of discordance, summarizing the panel discussion for each grant proposal, and working with the scientific review officer in panel management and training.

“I’m very excited to take on this new leadership role at the NIH,” says Brown, who served a two-year term as a standing study section member in the SIHH before being named chair. “I think it’s a great opportunity for Dartmouth to further develop its positioning in the implementation science field nationally and internationally.”

Brown is the principal investigator on several national NIH-funded clinical trials focused on implementation science and clinical informatics. Supported by team members Meagan Stabler, PhD, Iben Sullivan, PhD, MPH, Kevin Cox, Devin Parker, MS, Elizabeth Carpenter-Song, PhD, Todd MacKenzie, PhD, and James O’Malley, PhD, MS, along with national collaborators, the team is leading two national randomized implementation trials to improve adoption of evidence-based practices and guidelines in preventing major complications including acute kidney injury, peri-operative bacterial transmission, and infections. In addition, his team also specializes in clinical informatics using electronic health record data and clinical notes to predict healthcare encounters.

Brown also collaborates with other leaders in the field to develop guidelines for organizations such as the Acute Kidney Injury Network, the International Consortium of Evidence Based Perfusion, and the Workforce on Cardiopulmonary Bypass for the Society for Thoracic Surgeons. He is the lead author on the Society of Thoracic Surgery acute kidney injury guidelines co-produced with the Society of Cardiovascular Anesthesiologists and the American Society of Extracorporeal Technology being released this fall.

In collaboration with Dean Compton, Kelly Aschbrenner, PhD, Sarah Lord, PhD, and faculty across all of Dartmouth, Brown is working to build a new Center for Implementation Science that will serve as an axis for faculty, staff, and students to develop expertise and independence in implementation science.

Founded in 1797, the Geisel School of Medicine at Dartmouth strives to improve the lives of the communities it serves through excellence in learning, discovery, and healing. The Geisel School of Medicine is renowned for its leadership in medical education, healthcare policy and delivery science, biomedical research, global health, and in creating innovations that improve lives worldwide. As one of America’s leading medical schools, Dartmouth’s Geisel School of Medicine is committed to training new generations of diverse leaders who will help solve our most vexing challenges in healthcare.